Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative Bioavailability and PK of BI 11634 in Healthy Volunteers
NCT02214927Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2007
- Primary completion
- Jul 2007
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of BI 11634 in thromboembolism (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Number of subjects with adverse events, Number of subjects with clinically significant findings in vital signs and 5 more. Started May 2007; status: completed.
02
Drugs
BI 11634
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02214927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02214927.